One unique feature of the ETV4AAA-driven murine prostate cancer model is that it maintains the characteristics of early-stage human prostate cancers, including prostate differentiation markers, such as Nkx3.1 expression. The gene discussed is NKX3-1; the disease is prostate carcinoma.